Exosome Therapy for Male Androgenetic Alopecia
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating the Efficacy and Safety of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Male Androgenetic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 2
- Sponsor
- Zhang Han
- Participants (registry)
- 120
- Start
- April 2026
- Primary completion
- November 2026 (planned)
- Study completion
- November 2026 (planned)
- Last registry update
- July 2026
- Countries
- China
Conditions studied: Androgenetic Alopecia (AGA)
Interventions: Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes, Normal Saline (0.9% NaCl)
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.